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Abstract
Background: c-Jun/AP-1 has been linked to invasive properties of aggressive breast cancer.
Recently, it has been reported that overexpression of c-Jun in breast cancer cell line MCF-7
resulted in increased AP-1 activity, motility and invasiveness of the cells in vitro and tumor formation
in nude mice. However, the role of c-Jun in metastasis of human breast cancer in vivo is currently
unknown.
Methods: To further investigate the direct involvement of c-Jun in tumorigenesis and metastasis,
in the present study, the effects of c-Jun overexpression were studied in both in vitro and in nude
mice.
Results: Ectopic overexpression of c-Jun promoted the growth of MCF-7 cells and resulted in a
significant increase in the percentage of cells in S phase and increased motility and invasiveness.
Introduction of c-Jun gene alone into weakly invasive MCF-7 cells resulted in the transfected cells
capable of metastasizing to the nude mouse liver following tail vein injection.
Conclusion: The present study confirms that overexpression of c-Jun contributes to a more
invasive phenotype in MCF-7 cells. It indicates an interesting relationship between c-Jun expression
and increased property of adhesion, migration and in vivo liver metastasis of MCF-7/c-Jun cells. The
results provide further evidence that c-Jun is involved in the metastasis of breast cancer. The finding
also opens an opportunity for development of anti-c-Jun strategies in breast cancer therapy.
Background
The composite transcription factor activating protein-1
(AP-1) is thought to participate in fundamental cellular
processes and control cellular responses to stimuli that
regulate proliferation, differentiation, oncogenic transfor-
mation and apoptosis [1-5]. AP-1 proteins are composed
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principally of homodimers of Jun family members (c-Jun,
JunB, JunD) or heterodimers of the Jun family members
with the Fos family members (c-Fos, FosB, Fra-1, and Fra-
2) [6-9]. These homodimers or heterodimers bind to spe-
cific DNA sequences, known as 12-Otetradecanoylphor-
bol-13-acetate response elements (TRE), in the promoter
regions of target genes and activate transcription [10-13].
Among them, c-Jun is the major component of the AP-1
complex and c-Fos is its best-known partner. In vitro stud-
ies have demonstrated that Fos/Jun heterodimers are
more stable and efficient in driving transcriptional activa-
tion than a Jun/Jun homodimer [14].
c-Jun is frequently overexpressed in human cancers.
Increased c-Jun transcriptional activity and AP-1 mediated
gene expression are correlated with ras-transformation
[15-18]. Since tumor formation and TPA-induced inva-
sion of malignant epidermal cell lines could be blocked in
mice expressing a dominant negative transactivation
mutant of c-Jun (TAM67), the role of c-Jun in carcinogen-
esis has been suggested [19,20]. In liver tumors, c-Jun
antagonizes p53 by protecting tumor liver cells from
apoptosis. It was further demonstrated that c-Jun deletion
led to the accumulation of p53, the cyclin-dependent
kinase inhibitor p21 and retinoblastoma (Rb), and apop-
tosis in experimentally induced c-Jun-/- liver tumors
[21,22]. The role of c-Jun on angiogenesis in rodents was
also described [23].
c-Jun/AP-1 has been linked to invasive properties of
aggressive breast cancer [24-27]. Recently, it was reported
that overexpression of c-Jun in breast cancer cell line MCF-
7 resulted in increased AP-1 activity, motility and inva-
siveness of the cells in vitro and tumor formation in nude
mice [25]. The cells expressing dominant-negative c-Jun
fail to invade in response to EGF [28]. However, the asso-
ciation of c-Jun overexpression with tumor metastasis in
vivo has not been demonstrated.
The process of invasion and metastasis depends on the co-
ordinate expression and function of a number of gene
products conferring the ability of tumor cells to success-
fully complete a series of events that include breaking
away from the primary tumor, invading through base-
ment membrane barriers and the extracellular matrix
(ECM) to colonize distant sites in the organism [29]. In
the present study, involvement of c-Jun in invasiveness
and metastasis both in vitro and in vivo was investigated by
ectopic overexpression of c-Jun in breast cancer cell line
MCF-7 and MCF-7/c-Jun xenograft model.
Methods
Breast cancer cell lines
Human breast cancer cell line MCF-7 was obtained from
American Type Tissue Culture Collection (Rockville, MD)
and grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum
(FCS), 1 mM glutamine and antibiotics.
Construct and transfection
The cDNA encoding c-Jun protein was amplified by
reverse transcription PCR (RT-PCR) with primers 5'-ggaat-
tccaccatgactgcaaagatggaaacgacct-3' (EcoRI site underlined)
and 5'-cgggatcccgttatcaaaatgtttgcaactgctgcgtt-3' (BamH site
underlined) and LA Taq DNA polymerase (TaKaRa). The
RT-PCR products were then inserted into the vector
pCDNA3.1 by EcoRI and BamHI sites (pCDNA3.1/c-Jun).
MCF-7 cells were transfected with pCDNA3.1/c-Jun by
using Lipofectamin PLUS reagent (Gibco BRL) according
to the manufacturer's protocol. The empty vector was used
as a control. To obtain transfectants stably expressing c-
Jun, the transfected MCF-7 cells were selected in the pres-
ence of G418 at a concentration of 800 μg/ml (Sigma).
Single neomycin-resistant clones were picked and culti-
vated in the presence of G418 (200 μg/ml).
Cell lysate preparation and Western blot
The cells were lysed in ice-cold lysis buffer [50 mM Tris.Cl,
pH 7.4, 100 mM NaCl, 10% glycerol, 1% Nonidet P-40, 1
× cocktail protein inhibitors (Roche)] and centrifuged at
10 000 × g at 4°C for 10 minutes. Supernatants were
transferred to new tubes. Samples were denatured by
being heated to 100°C prior to fractionation onto SDS-
PAGE gels. After transfer to nitrocellulose membranes, fil-
ters were blocked for 1 hour in blocking buffer [50 mM
Tris.Cl, pH 7.5, 100 mM NaCl (Tris-buffered saline, TBS)
containing 5% dry milk and 0.2% Tween-20] and then
incubated for 1 hour with the primary antibody against c-
Jun [c-Jun (H-79): sc-1694, Santa Cruz Biotechnology,
Inc.] diluted in blocking buffer. After being washed with
TBS (50 mM Tris.Cl, pH 7.5, 100 mM NaCl, 0.2% Tween-
20), filters were incubated with horseradish peroxidase-
conjugated secondary antibody (Beijing Zhongshan
Golden Bridge Biotechnology Co. LTD) for 30 minutes
and bands detected by SuperSignal® West Femto Maxi-
mum Sensitivity Substrate (PIERCE).
Proliferation
In vitro proliferation of MCF-7 cells was measured over 5
days with an initial cell density of 3.5 × 103/well and six
replicate wells/time point by MTT assay as follows. The
medium in each well was replaced with 100 μl of medium
containing MTT at 0.5 μg/μl and plates were returned to
the incubator for 4 hours. The medium-MTT was then
removed and 100 μl of dimethyl sulfoxide added to eachBMC Cancer 2007, 7:145 http://www.biomedcentral.com/1471-2407/7/145
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well. The plates were kept in agitation for 10 minutes in
the dark to dissolve the MTT-formazan crystals. The
absorbance of the samples was recorded at 570 nm. The
results are presented as the mean ± the standard deviation
(SD). The experiment was repeated for three times.
MCF-7 cells were washed twice with cold phosphate-buff-
ered saline (PBS) and fixed in cold 70% (v/v) ethanol at
4°C for at least 18 h. Then the cells were harvested and
sequentially incubated with RNase A (100 μg/ml) at 37°C
for 30 minutes and stained with propidium iodide (PI)
(50 μg/ml) in the dark at 4°C for 20 minutes. DNA con-
tent was measured by a FACScan cytometer (Becton Dick-
inson). The experiment was repeated twice.
Adhesion assays
For adhesion assay, briefly, triplicate wells were precoated
overnight at 4°C with BSA (1% w/v), Matrigel diluted 1:8
in DMEM and fibronectin (10 μg/ml). The cells were
seeded at 1 × 104/100 μl in serum-free DMEM supple-
mented with 0.1% BSA. The cells were allowed to adhere
for 1 hour at 37°C. Nonadherent cells were removed by
gentle washing with PBS and adherent cells were evalu-
ated with MTT method and OD570 nm determination.
The experiment was conducted in triplicate.
Wound migration assay
Cells were cultured in DMEM supplemented with 10%
FCS on Matrigel (diluted 1:10 in DMEM)-coated 96-well
plates for 24 hours. The injury lines were made with a tip
on the cells grown at >90% confluency. After being rinsed
with serum free DMEM, cells were allowed to migrate in
DMEM supplemented with 1% FCS. The area of cell-free
wound was photographed with an inverted microscope
(Nikon, Tokyo, Japan) equipped with a digital camera
(Spot, Diagnostic Instruments, Inc., Sterling Heights, MI)
at indicated time points. The wound healing effect was
calculated as the ratio of leading edge to initial wound
length. The experiment was performed by duplicate.
In vivo studies
Five-week-old female Balb/C athymic nude mice were
purchased from the Institute of Laboratory Animal Sci-
ence, Chinese Academy of Medical Science and housed in
specific pathogen-free conditions in Good Laboratory
Practice facility. For all studies, the mice were allowed to
acclimate at least 3 days after receipt of shipment and
caged in groups of 6. Before injection, the cells were
washed with PBS, harvested by trypsinization, resus-
pended and kept on ice until injection. Precise cell counts
were obtained from samples of the cell suspensions by
using a hemocytometer. 2 × 107 MCF-7 or MCF-7/c-Jun
cells suspended in 200 μl of PBS were injected s.c. in the
right flank. For experimental lung or liver metastasis
assays, mice were injected intravenously with 3 × 106
tumor cells in a volume of 200 μl via the lateral tail vein.
Primary tumors, lungs and livers were autopsied 3–4
weeks post injection and tissues with metastases were
either photographed for gross morphology or processed
for histology as described in the following.
Histology
Tissues were dissected and fixed in 10% buffered formalin
and embedded in paraffin wax. Tissue sections (4 μm)
were stained with H & E for morphology. The photo-
graphs were taken on a Nikon microscope.
Statistical analysis
Data were expressed as mean ± SD. For proliferation and
adhesion assay, the data were compared by the Mann-
Whitney test. For wound migration assay, the compari-
sons were made by repeated-measures ANOVA as appro-
priate. P < 0.05 was considered statistically significant.
Results
Effect of c-Jun expression on the proliferation and cell 
cycle of MCF-7 cells
In order to investigate the effects of c-Jun on tumorigene-
sis and metastasis of breast cancer cells, pCDNA3.1/c-Jun
was transfected into MCF-7 cells. The transfected MCF-7
cells were selected in levels of Geneticin (G418) up to 800
μg/ml for stable c-Jun expression. Individual neomycin-
resistant colonies (MCF-7/c-Jun) from pCDNA3.1/c-Jun
transfections were isolated, expanded and analyzed for c-
Jun expression. Western blot analysis of expression of c-
Jun protein in individual clones of stable transfectants is
Western blot analysis of c-Jun expression in individual clones  of stable transfectants Figure 1
Western blot analysis of c-Jun expression in individ-
ual clones of stable transfectants. Cell lysates were sub-
jected to SDS-PAGE, transferred to nitrocellulose 
membrane, and incubated with the primary antibody against 
c-Jun and horseradish peroxidase-conjugated secondary anti-
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illustrated in Fig. 1. Compared to mock transfection, a
considerable increase of c-Jun expression with an appar-
ent molecular weight 39 kDa was observed in MCF-7/c-
Jun cells. A significant difference in the increase of c-Jun
protein expression was found in clones 1 and 4 of stable
MCF-7/c-Jun transfectants. Clone 1 was then used in the
following experiments.
To evaluate the effect of c-Jun overexpression on the
growth of MCF-7 cells, clone 1 was cultured for continu-
ous five days and proliferation of MCF-7/c-Jun cells was
measured in an MTT-based assay. Fig. 2A shows that the
expression of c-Jun significantly promoted MCF-7 cell
proliferation (P < 0.01) compared with mock transfected
MCF-7 cells. To determine the effect of c-Jun expression
on cell cycle progression, the cells were analyzed by PI
staining and flow cytometry. A significant increase in S
phase cells (from 10.68% to 28.63%) could be observed
in MCF-7 cells overexpressing c-Jun, indicating the
involvement of c-Jun in positive regulation of cell cycle
(Fig. 2B and 2C).
Effect of c-Jun expression on the adhesion and motility of 
MCF-7 cells
The process of tumor cell invasion involved in tumor cell
adhesion to the basement membrane, degradation/prote-
olysis of the basement membrane and tumor cell migra-
tion into secondary sites. Cell movement is generally a
continuous and dynamic interplay of adhesions at the
leading edge and deadhesions at the rear portion of the
cells. A certain degree of cell attachment to ECM substrates
is necessary for cell motility. Tumor cell lines that are
highly invasive and metastatic exhibit a higher degree of
adhesion and motility than their lower metastatic coun-
terparts. To investigate the effect of c-Jun expression on
the adhesion and motility of MCF-7 cells, the adhesive
ability of MCF-7/c-Jun cells was compared with MCF-7/
pCDNA3.1 cells. As shown in Fig. 3A, expression of c-Jun
effectively increased adhesion of transfected MCF-7 cells
to dishes coated with the Matrigel (P < 0.05).
Next the cell motility and the invasive capacity of MCF-7/
c-Jun cells were analyzed in a classical wound migration
assay. Cell motility into the Matrigel-coated area was
determined from micrographs taken at various time
points. Compared with the control cells, the motility
MCF-7/c-Jun cells was significantly increased (Fig. 3B and
3C), indicating that ectopic expression of c-Jun promoted
cell movement (p < 0.01).
Effect of c-Jun overexpression on potential of MCF-7 
tumor formation and liver metastases in nude mice
The effect of c-Jun overexpression on tumor formation in
nude mice was investigated by injecting 2 × 107 cells sub-
cutaneously into mice. The tumor growth was observed in
4/6 mice injected with MCF-7/c-Jun cells, but parental
MCF-7 cells did not produce tumors. Histologically, the
tumors were composed of relatively large cells that differ
in size and displayed areas with glandula-like arrange-
ment of tumor cells (Fig. 4A). The overall tumor morphol-
ogy was essentially similar to that observed in poorly
Effect of c-Jun expression on the proliferation and cell cycle  of MCF-7 cells Figure 2
Effect of c-Jun expression on the proliferation and 
cell cycle of MCF-7 cells. A, proliferation assay. Cells (3.5 
× 103/well) were cultured for continuous five days and prolif-
eration of MCF-7/c-Jun cells was measured in an MTT-based 
assay. ** P < 0.01 B and C, cell cycle analysis. MCF-7 cells 
were washed with cold PBS and fixed in cold 70% (v/v) etha-
nol at 4°C for at least 18 hours. Then the cells were incu-
bated with RNase A (100 μg/ml) at 37°C for 30 minutes and 
stained with propidium iodide (PI) (50 μg/ml) in the dark at 
4°C for 20 minutes. DNA content was measured by flow 
cytometry. Striped column, G0-G1 phase; empty column, 
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Effect of c-Jun overexpression on potential of MCF-7 tumor  formation Figure 4
Effect of c-Jun overexpression on potential of MCF-7 
tumor formation. 2 × 107 MCF-7 or MCF-7/c-Jun cells sus-
pended in 200 μl of PBS were injected s.c. in the right flank. 
After 3–4 weeks, tumor tissues were dissected and fixed in 
10% buffered formalin and embedded in paraffin wax. Tissue 
sections (4 μm) were stained with H & E for morphology. 
The photographs were taken on a Nikon microscope. A, the 
tumors are composed of relatively large cells that differ in 
size and display areas with glandula-like arrangement of 
tumor cells. B, the blood vessels were visualized in the tumor 
tissues. C, the tumors were highly invasive in the surrounding 
muscle tissue. ← blood vessels ×400 magnification.
Effect of c-Jun expression on the adhesion and motility of  MCF-7 cells Figure 3
Effect of c-Jun expression on the adhesion and motil-
ity of MCF-7 cells. A, Adhesion assay. Triplicate wells were 
precoated overnight at 4°C with BSA (1% w/v), Matrigel 
diluted 1:8 in DMEM and fibronectin (10 μg/ml). The cells 
were seeded at 1 × 104/100 μl in serum-free DMEM supple-
mented with 0.1% BSA and allowed to adhere for 1 hour at 
37°C. Nonadherent cells were removed by gentle washing 
with PBS and adherent cells were evaluated with MTT 
method and OD570 nm determination. B and C, Wound 
migration assay. **P < 0.05 Cells were cultured in DMEM 
supplemented with 10% FCS on Matrigel (diluted 1:10 in 
DMEM)-coated 96-well plates for 24 hours. The injury line 
was made on the cells grown at >90% confluency. After being 
rinsed with serum free DMEM, cells were allowed to migrate 
in DMEM supplemented with 1% FCS, and photographs were 
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differentiated adenocarcinoma. The tumor cells were sep-
arated by bundles of extracellular matrix and blood ves-
sels visualized. The tumors were highly invasive in the
surrounding muscle tissue (Fig. 4B and 4C). Mitosis could
be found.
Then the effect of c-Jun overexpression on the metastatic
potential was investigated by injecting MCF-7/c-Jun cells
intravenously into nude mice. Six mice were monitored
for lung and liver metastases. Metastatic colonization was
evaluated by gross examination and microscopic inspec-
tion of tissue sections. Three of six mice developed visible
liver metastases within 30 days. Livers with MCF-7/c-Jun
cell derived metastases were enlarged. A clear external
image of multiple metastatic lesions of livers was
observed in the mice injected with MCF-7/c-Jun cells by
gross examination, but no visible metastatic nodules in
the livers of mice injected with MCF-7 cells (Fig. 5A). The
livers from each group were removed and processed for
histological examination. Microscopic examination of
liver tissue sections revealed a massive infiltration of the
liver by MCF-7/c-Jun derived tumor cells (Fig. 5B), but no
liver infiltration by parental cells was observed (Fig. 5C).
The tumor morphology was comparable to that observed
in sections from subcutaneous tumors. Tumor cells in
metastatic foci included a heterogeneous population of
cells consisting of tumor epithelial cells, as well as associ-
ated endothelial cells and stroma cells. Large metastases
showed central necrosis. Lung metastasis was not
observed either by gross or by microscopic examination.
Discussion
c-Jun has been demonstrated to transduce a mitogenic
response and to involve in promoting cell growth as a sin-
gle gene or in cooperation with an activated ras gene
[15,16]. A critical role for c-Jun in the migration and inva-
sion characteristics of human breast cancer cell line in in
vitro experiment has been demonstrated [25]. The contri-
bution of c-Jun to metastatic phenotype in breast cancer
cells has also been studied in in vitro studies [25]. How-
ever, the role of c-Jun in metastasis of human breast can-
cer in vivo is currently unknown. In the present study, by
utilizing MCF-7 cell line as a cell model the effects of c-Jun
overexpression were studied in both in vitro and in vivo
experiments to further investigate the direct involvement
of c-Jun in tumorigenesis and metastasis.
c-Jun acts as a positive regulator of the cell cycle [30,31].
Our data indicated that ectopic overexpression of c-Jun
promoted the growth of MCF-7 cells and led to a signifi-
cant increase in the percentage of cells in S phase. It is pos-
sible that uncontrolled cell proliferation is an important
first step in tumorigenesis. Overexpression of c-Jun in
transfected MCF-7 cells results in increased motility and
invasiveness. Interestingly, introduction of c-Jun gene
Effect of c-Jun overexpression on potential of MCF-7 tumor  liver metastases in nude mice Figure 5
Effect of c-Jun overexpression on potential of MCF-7 
tumor liver metastases in nude mice. Mice were 
injected intravenously with 3 × 106 tumor cells in a volume of 
200 μl via the lateral tail vein. The livers were autopsied 3–4 
weeks post injection and tissues with metastases were pho-
tographed for gross morphology or processed for histology. 
A, the external image of multiple metastatic lesions of a liver. 
B, massive infiltration of the liver by MCF-7/c-Jun derived 
tumor cells observed by microscopic examination. C, no 
liver infiltration by parental cells was observed. ← liver tis-
sue; * metastasis ×400 magnification.BMC Cancer 2007, 7:145 http://www.biomedcentral.com/1471-2407/7/145
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alone into weakly invasive MCF-7 cells led to the trans-
fected cells capable of metastasizing to the nude mouse
liver following tail vein injection. For many years it had
been reported that many malignant human tumors did
not metastasize in the nude mouse. The production of
metastasis mostly depends on the intrinsic tumor cell
properties. Our data confirms that overexpression of c-Jun
contributes to a more invasive phenotype in MCF-7 cells.
This study is the first reported example of c-Jun overex-
pression inducing liver metastasis of MCF-7 cells in nude
mice.
Progression of breast cancer is often accompanied by
changes of gene expression pattern and requires an accu-
mulation of metastasis supporting genetic modifications.
AP-1 is thought to play a central role in reprogramming of
the gene expression pattern and regulating the expression
of genes directly necessary for cell invasion [27,32]. Sev-
eral AP-1-responsive genes with roles in facilitating the
invasion of malignant cells have been described [33-35].
The critical target genes activated by c-Jun/AP-1 in metas-
tasis of MCF-7/c-Jun cells remain to be defined.
Conclusion
In summary, the present study demonstrates an interest-
ing relationship between c-Jun expression and increased
property of adhesion, migration and liver metastasis of
MCF-7 breast cancer cells. The results provide further evi-
dence that c-Jun alone affects many aspects of the breast
cancer phenotype and is involved in the metastasis of
breast cancer. This finding also opens an opportunity for
development of anti-c-Jun strategies in breast-cancer ther-
apy.
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